IQVIAvsMerck & Company

IQV and MRK stock compared: price, dividend, valuation and results, from SEC filings.

IQV

IQVIA Holdings, Inc.

$257.84

Value $43.8B

+0.09%
IQV's page

MRK

Merck & Company, Inc.

$137.78

Value $341B

-3.90%
MRK's page

IQVIA (IQV) has a market value of $43.8B and Merck & Company (MRK) $341B. Over the last year, with dividends, IQV moved +19.3% and MRK +52.7%. The P/E is 31.4 for IQV and 138.9 for MRK. Dividend yield: IQV none, MRK 2.47%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    IQV$43.8B

    MRK$341B

    MRK is 7.8 times IQV

  • Revenue, 12 months

    IQV$17.3B

    MRK$67.4B

    MRK is 3.9 times IQV

  • Net income, 12 months

    IQV$1.4B

    MRK$2.5B

    MRK is 1.8 times IQV

  • Operating margin

    IQV12.8%

    MRK–

  • ROIC

    IQV8.4%

    MRK3.9%

    4.5 points apart

  • P/E

    IQV31.4

    MRK138.9

    MRK is 4.4 times IQV

  • Dividend yield

    IQV0.0%

    MRK2.5%

    2.5 points apart

  • 5-year return

    IQV-2.5%

    MRK+94.3%

    96.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

IQV-2.5%

MRK+94.3%

5010015020020222023202420252026
Returns by period
PeriodIQVWith dividendsMRKWith dividends
1 year since November 17, 2025+19.3%Price +19.3%+52.7%Price +48.4%
3 years since November 17, 2023+25.9%+8.0% a yearPrice +25.9%+48.4%+14.1% a yearPrice +35.4%
5 years since November 17, 2021-2.5%-0.5% a yearPrice -2.5%+94.3%+14.2% a yearPrice +66.8%
10 years since November 18, 2016+222.8%+12.4% a yearPrice +222.8%+216.6%+12.2% a yearPrice +133.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

IQVIQVIAMRKMerck & Company

Valuation

IQVMRK
Valuation
Price$257.84$137.78
Market value$43.8B$341B
Enterprise value (EV)$57.4B$385B
P/E31.4138.9
P/E, 5-year median31.714.8
P/B6.67.6
EV/EBIT25.980.8
Free cash flow yield4.8%4.3%

Results and growth

IQVMRK
Results and growth
Revenue, 12 months$17.3B$67.4B
Net income, 12 months$1.4B$2.5B
Free cash flow, 12 months$2.1B$14.7B
Earnings per share, 12 months$8.22$0.98
Revenue growth, year on year5.9%1.3%
Revenue growth a year, past+7.5%over 5 years+9.4%over 5 years
EPS growth a year, past+40.5%over 5 years+21.2%over 5 years

Margins and returns on capital

IQVMRK
Margins and returns on capital
Gross margin33.1%71.8%
Operating margin12.8%–
Net margin8.1%3.6%
ROIC8.4%3.9%
ROE22.0%5.2%

Balance sheet

IQVMRK
Balance sheet
Cash$2.4B$9.7B
Total debt$16.3B$53.8B
Net debt / EBITDA4.15.7
Interest cover2.8×2.4×

Dividends and buybacks

IQVMRK
Dividends and buybacks
Dividend yield–2.5%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield2.8%1.5%
Shareholder yield2.8%4.0%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: IQV or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, IQVIA or Merck & Company?

By market value, Merck & Company ($341B) is about 7.8 times IQVIA ($43.8B), at today's prices.

How did IQV and MRK stock do over the last 10 years?

Since November 18, 2016, IQV's price moved +222.8% and MRK's +133.4%. With dividends: IQV +222.8% (+12.4% a year), MRK +216.6% (+12.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, IQV or MRK?

The dividend yield at today's price is none for IQVIA and 2.47% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

What is the P/E of IQV and MRK?

At today's price, the P/E is 31.4 for IQV and 138.9 for MRK. The median of the last five years was 31.7 and 14.8, which shows where each stands against its own past.

Which has the higher profit margins, IQVIA or Merck & Company?

Over the last twelve months, the net margin was 8.1% for IQVIA and 3.6% for Merck & Company, and the operating margin 12.8% and –. Revenue was $17.3B and $67.4B.

Which is the better investment, IQVIA or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.